AstraZeneca (AZN) News Today $73.95 +0.86 (+1.18%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$73.50 -0.45 (-0.61%) As of 08/1/2025 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AZN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period AstraZeneca (NASDAQ:AZN) Announces Quarterly Earnings Results, Hits ExpectationsJuly 31 at 4:48 PM | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Declares Semi-annual Dividend of $0.51July 31 at 4:29 PM | marketbeat.comAstraZeneca (LSE:AZN) Advances Lung Cancer Care With Revna Biosciences In GhanaJuly 31 at 3:34 PM | finance.yahoo.comNatixis Advisors LLC Has $164.35 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)July 31 at 6:51 AM | marketbeat.comLPL Financial LLC Has $64.91 Million Position in AstraZeneca PLC (NASDAQ:AZN)July 31 at 5:02 AM | marketbeat.comAccelerating Impact: AstraZeneca and Revna Biosciences Expand Access to Lung Cancer Treatment in GhanaJuly 30 at 1:24 PM | businesswire.comHealthy Returns: AstraZeneca CEO proposes some U.S. drug price cuts amid Trump pressureJuly 30 at 9:55 AM | cnbc.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by Thornburg Investment Management Inc.July 30 at 7:48 AM | marketbeat.comCozad Asset Management Inc. Sells 15,540 Shares of AstraZeneca PLC (NASDAQ:AZN)July 30 at 5:09 AM | marketbeat.comMackenzie Financial Corp Sells 127,188 Shares of AstraZeneca PLC (NASDAQ:AZN)July 30 at 4:33 AM | marketbeat.comAstraZeneca PLC (AZN) Q2 2025 Earnings Call TranscriptJuly 29, 2025 | seekingalpha.comAstraZeneca PLC 2025 Q2 - Results - Earnings Call PresentationJuly 29, 2025 | seekingalpha.comAstraZeneca CEO doubles down on U.S. amid rumors of listing shiftJuly 29, 2025 | cnbc.comAstraZeneca Q2 Sales Beat Estimates On Strong Cancer Drugs Revenues, Reaffirms 2025 OutlookJuly 29, 2025 | benzinga.comAstraZeneca Stock Rises as US, Cancer Drug Growth Lifts Q2 ResultsJuly 29, 2025 | investopedia.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by First Foundation AdvisorsJuly 29, 2025 | marketbeat.comRamirez Asset Management Inc. Reduces Position in AstraZeneca PLC (NASDAQ:AZN)July 29, 2025 | marketbeat.comCetera Investment Advisers Buys 56,449 Shares of AstraZeneca PLC (NASDAQ:AZN)July 29, 2025 | marketbeat.comAstraZeneca beats second-quarter profit expectations, maintains outlookJuly 29, 2025 | reuters.comCelcuity's triple cancer drug combo tops AstraZeneca's in cutting progression in studyJuly 28, 2025 | reuters.comKFA Private Wealth Group LLC Makes New $270,000 Investment in AstraZeneca PLC (NASDAQ:AZN)July 28, 2025 | marketbeat.comTexas Yale Capital Corp. Has $734,000 Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)July 28, 2025 | marketbeat.comTD Asset Management Inc Sells 162,735 Shares of AstraZeneca PLC (NASDAQ:AZN)July 28, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Purchased by HB Wealth Management LLCJuly 28, 2025 | marketbeat.comHere’s where the AstraZeneca share price could end the yearJuly 28, 2025 | msn.comAstraZeneca PLC (NASDAQ:AZN) Stock Position Raised by FourThought Financial Partners LLCJuly 27, 2025 | marketbeat.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by MotcoJuly 27, 2025 | marketbeat.comAssetmark Inc. Acquires 26,014 Shares of AstraZeneca PLC (NASDAQ:AZN)July 27, 2025 | marketbeat.comAstraZeneca (AZN) Expected to Announce Earnings on TuesdayJuly 27, 2025 | americanbankingnews.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Phoenix Financial Ltd.July 26, 2025 | marketbeat.comAstraZeneca’s Gefurulimab Shows Promise in Phase III Trial for Myasthenia GravisJuly 26, 2025 | theglobeandmail.comAstraZeneca's eco-friendly version of smoker's lung inhaler gets EU panel backingJuly 25, 2025 | reuters.comAtria Investments Inc Increases Stock Holdings in AstraZeneca PLC (NASDAQ:AZN)July 25, 2025 | marketbeat.comOne Wealth Advisors LLC Buys Shares of 3,534 AstraZeneca PLC (NASDAQ:AZN)July 25, 2025 | marketbeat.comSFE Investment Counsel Takes $523,000 Position in AstraZeneca PLC (NASDAQ:AZN)July 24, 2025 | marketbeat.comAstraZeneca's immune disorder drug succeeds in late-stage trialJuly 24, 2025 | reuters.com32,855 Shares in AstraZeneca PLC (NASDAQ:AZN) Bought by Y Intercept Hong Kong LtdJuly 23, 2025 | marketbeat.comJ.W. Cole Advisors Inc. Raises Position in AstraZeneca PLC (NASDAQ:AZN)July 23, 2025 | marketbeat.comKestra Private Wealth Services LLC Raises Stake in AstraZeneca PLC (NASDAQ:AZN)July 23, 2025 | marketbeat.comTrending tickers: AstraZeneca, Verizon, Opendoor, Trump Media and Lindt & SpruengliJuly 22, 2025 | msn.comLockheed Martin, AstraZeneca, DR Horton: Trending TickersJuly 22, 2025 | finance.yahoo.comAstraZeneca Announces $50B US Investment Amid Pharma Tariff ThreatJuly 22, 2025 | uk.finance.yahoo.comAstraZeneca (AZN) Commits to $50B U.S. Investment as Tariff Threat LoomsJuly 22, 2025 | msn.comAstraZeneca PLC (NASDAQ:AZN) Shares Sold by Zevin Asset Management LLCJuly 22, 2025 | marketbeat.comDeDora Capital Inc. Takes Position in AstraZeneca PLC (NASDAQ:AZN)July 22, 2025 | marketbeat.comAstraZeneca to invest $50B in US to boost drug manufacturing and R&DJuly 22, 2025 | proactiveinvestors.comProficio Capital Partners LLC Grows Stake in AstraZeneca PLC (NASDAQ:AZN)July 22, 2025 | marketbeat.com5 Things to Know Before the Stock Market OpensJuly 22, 2025 | investopedia.comOneAscent Financial Services LLC Acquires 4,476 Shares of AstraZeneca PLC (NASDAQ:AZN)July 22, 2025 | marketbeat.comAstraZeneca Plans to Invest $50B in US Manufacturing and Research by 2030July 22, 2025 | investopedia.com Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address AZN Media Mentions By Week AZN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AZN News Sentiment▼1.120.63▲Average Medical News Sentiment AZN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AZN Articles This Week▼3327▲AZN Articles Average Week Get AstraZeneca News Delivered to You Automatically Sign up to receive the latest news and ratings for AZN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Novo Nordisk A/S News Novartis News Sanofi News GSK News Takeda Pharmaceutical News argenex News BeOne Medicines News BioNTech News Summit Therapeutics News Insmed News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AZN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AstraZeneca PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share AstraZeneca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
